Anthera plummets after discontinuing development of varespladib

Anthera Pharmaceuticals Inc. (NASDAQ:ANTH) fell $2.86 (45%) to $3.56 on Monday after announcing late Friday that it will discontinue development of cardiovascular compound varespladib for all indicati...